NervGen Pharma Announces Granting of US Patent for Breakthrough Nerve Regeneration Technology

World News: . []

VANCOUVER British Columbia, Aug 10 2018 GLOBE NEWSWIRE -- NervGen a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage, announces the issuance by the US Patent and Trademar k Offic...

More news and information about NervGen Pharma Corp.

Published By:

Globe Newswire: 13:00 GMT Friday 10th August 2018

Published: .

Search for other references to "nervgen" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us